Legend Biotech (LEGN) EBT Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -148.52% |
| Sep 30, 2025 | 67.68% |
| Jun 30, 2025 | -594.48% |
| Mar 31, 2025 | 65.80% |
| Dec 31, 2024 | 27,754.42% |
| Sep 30, 2024 | -93.43% |
| Jun 30, 2024 | 90.96% |
| Mar 31, 2024 | -46.60% |
| Dec 31, 2023 | 99.89% |
| Sep 30, 2023 | 26.31% |
| Jun 30, 2023 | -2.99% |
| Mar 31, 2023 | 448.54% |
| Dec 31, 2022 | -53.65% |
| Sep 30, 2022 | 32.02% |
| Jun 30, 2022 | -110.82% |
| Mar 31, 2022 | -33,858.75% |
| Dec 31, 2021 | -52.95% |
| Sep 30, 2021 | -86.05% |
| Jun 30, 2021 | 32.10% |
| Mar 31, 2021 | 99.80% |
| Dec 31, 2020 | 6.37% |
| Sep 30, 2020 | -141.27% |
| Jun 30, 2020 | -373.81% |